CSIMarket Company Name, Ticker, Industry, else..
 
Hookipa Pharma inc   (NASDAQ: HOOK)
Other Ticker:  
 
 

Hookipa Pharma Inc Growth Comparisons

Select each growth Category to receive further Information



HOOK Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -31.51 % 9.73 % 7.33 % 4 %
Q / Q Revenue Growth (Q3 MRQ) 264.57 % 3.93 % 2.74 % 0.39 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 143.3 % 2.75 % 5.63 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) -4.15 % 2.56 % 1.78 % 1.12 %
Revenue 5 Year Average Growth - 8.81 % 8.02 % 7.61 %


HOOK's Growth Comparisons in III. Quarter 2024




Hookipa Pharma Inc 's Revenue were slashed by -31.51% in the third quarter 2024 from the same quarter a year ago, to $ 5 millions, while sales in theMajor Pharmaceutical Preparations industry grew by 9.73%, and underperformed the 7.33% Revenue growth in the Healthcare sector. Although both Major Pharmaceutical Preparations industry and Healthcare sector posted higher gains than 4% overall market increase, Hookipa Pharma Inc was trailing overall market in the third quarter.

Company's sequential Revenue growth rate was impressive 264.57% from the second quarter. Average yearly sales growth for Hookipa Pharma Inc is %, while S & P 500's average annual sales growth is 7.61% over the five years, including only Businesses with the third quarter 2024 financial reports.

HOOK Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
-31.51 %
264.57 %


Growth Rates of HOOK's Income in the third quarter 2024


HOOK Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 90.11 % 79.67 % 4.45 %
Seq. Operating Income Change (Q3 MRQ) - 42.04 % 32.65 % -2.32 %
Y / Y Operating Income Growth (Q3 TTM) - -32.12 % -6.23 % 9.3 %
Seq. Operating Income Growth (Q3 TTM) - 29.29 % 19.49 % 1.41 %
Operating Income 5 Year Avg. Change - 3.06 % 6.12 % 9.13 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 164.18 % 297.79 % -1.43 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 59.79 % 118.23 % -8.76 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - -1.56 % 24.99 % 8.89 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - 42.28 % 55.93 % -0.02 %
Income from Cont. Ops. 5 Year Avg. Change - -3.62 % -9.72 % 7.31 %

HOOK Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - -38.86 % 7.75 % -6.22 %
Q / Q Net Income Growth (Q3 MRQ) - 59.57 % 131.96 % -6.76 %
Y / Y Net Income Change (Q3 TTM) - -40.98 % -11.95 % 5.26 %
Seq. Net Income Change (Q3 TTM) - -25.9 % 1.81 % -1.37 %
Net Income 5 Year Avg. Growth - 4.44 % -3.38 % 7.45 %

HOOK's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 160.34 % 297.79 % -1.43 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 58.79 % 118.23 % -8.76 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -16.63 % -9.72 % 7.31 %



HOOK EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - -39.75 % 7.75 % -6.22 %
Q / Q EPS Net Growth (Q3 MRQ) - 58.57 % 131.96 % -6.76 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - 4.44 % -3.38 % 7.45 %



Hookipa Pharma Inc reported bottom-line of $ -1.10 in the third quarter, compare to $ -1.70 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -39.75%, while Healthcare sector increased by 7.75%, and overall market declined by -6.22%.

The Company's sequential EPS growth rate was very impressive 264.57% from the second quarter. Average yearly income per share growth for Hookipa Pharma Inc is %, while S & P 500's average annual income per share growth is 7.45% over the five years, including only Businesses with the third quarter 2024 earnings results.

HOOK Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 38.13 % 38.09 % -42.75 %
Seq. Free Cash Flow Change (Q3 MRQ) - 201.53 % 108.45 % -36.75 %
Y / Y Free Cash Flow Change (Q3 TTM) - 0.9 % 4.69 % 3.44 %
Seq. Free Cash Flow Change (Q3 TTM) - 8.08 % 8.11 % -10.82 %
Free Cash Flow 5 Year Avg. Change - 11.97 % 7 % 11.94 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -74.08 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 1.43 % 11.17 % -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) -98.97 % 2 % 1.43 % 2.78 %
Seq. Capital Expenditures Change (Q3 MRQ) -31.11 % 9.69 % 5.75 % 2.91 %
Y / Y Capital Expenditures Change (Q3 TTM) -85.84 % 5.61 % 3.08 % 70.28 %
Seq. Capital Expenditures Change (Q3 TTM) -82.95 % 1.68 % 2.03 % -0.52 %
Capital Expenditures 5 Year Avg. Change - 13.67 % 9.35 % 8.99 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com